Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstroms”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)UnknownNCT01142011
What this trial is testing

Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

Who this might be right for
Symptomatic Waldenstroms Macroglobulinaemia
Cancer Trials Australia 15
Not applicableWithdrawnNCT02298816
What this trial is testing

B-Cell Hematologic Malignancy Vaccination Registry

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia+4 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00250926
What this trial is testing

Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT00832234
What this trial is testing

Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia

Who this might be right for
Waldenstroms Macroglobulinemia
European Myeloma Network B.V. 59
Large-scale testing (Phase 3)Ended earlyNCT00714259
What this trial is testing

Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

Who this might be right for
Multiple MyelomaCLL / SLLNon Hodgkin's Lymphoma+2 more
University of Alabama at Birmingham 5
Testing effectiveness (Phase 2)Looking for participantsNCT04728893
What this trial is testing

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Who this might be right for
Hematologic MalignanciesWaldenstroms MacroglobulinaemiaNon-Hodgkins Lymphoma+1 more
Merck Sharp & Dohme LLC 490
Early research (Phase 1)Looking for participantsNCT06667687
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
AbbVie 165